RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%
Last update at 2024-11-20T20:43:00Z
State Street Corp's Strategic Acquisition of FMC Corp Shares
Thu 17 Oct 24, 05:01 PMZacks Industry Outlook DuPont de Nemours, FMC and Cabot
Wed 09 Oct 24, 07:15 AM3 Diversified Chemical Stocks to Escape Industry Challenges
Tue 08 Oct 24, 11:37 AMHere's Why You Should Add FMC Stock to Your Portfolio Now
Mon 07 Oct 24, 02:20 PMFMC Partners Ballagro to Expand Biologicals Crop Protection in Brazil
Thu 03 Oct 24, 09:46 AMFMC Stock Rises 18% in 3 Months: What's Driving the Rally?
Wed 02 Oct 24, 07:00 PMFMC (NYSE:FMC) Will Pay A Dividend Of $0.58
Mon 23 Sep 24, 11:10 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 983.90M | 893.80M | 729.80M | 655.00M | 608.40M |
Minority interest | -5.00000M | 2.50M | -0.90000M | -2.80000M | 9.40M |
Net income | 736.50M | 736.50M | 551.50M | 477.40M | 502.10M |
Selling general administrative | 775.20M | 714.10M | 729.70M | 792.90M | 851.20M |
Selling and marketing expenses | - | - | - | - | 61.20M |
Gross profit | 2326.80M | 2171.70M | 2052.00M | 2083.60M | 1879.80M |
Reconciled depreciation | 169.40M | 170.90M | 162.70M | 150.10M | 168.20M |
Ebit | 1059.40M | 962.00M | 850.50M | 834.40M | 634.50M |
Ebitda | 1228.80M | 1132.90M | 1013.20M | 984.50M | 802.70M |
Depreciation and amortization | 169.40M | 170.90M | 162.70M | 150.10M | 168.20M |
Non operating income net other | - | - | 0.10M | 1.90M | 1.50M |
Operating income | 1059.40M | 962.00M | 850.50M | 834.40M | 725.40M |
Other operating expenses | 4564.90M | 3892.30M | 3607.70M | 3617.20M | 3483.20M |
Interest expense | 151.80M | 131.10M | 151.20M | 158.50M | 133.10M |
Tax provision | 145.20M | 91.60M | 150.90M | 111.50M | 88.80M |
Interest income | 151.80M | 131.10M | 0.10M | 1.90M | 1.40M |
Net interest income | -151.80000M | -131.10000M | -151.20000M | -158.50000M | -133.10000M |
Extraordinary items | -97.20000M | -68.20000M | -28.30000M | -63.30000M | -33.90000M |
Non recurring | 93.10M | 108.00M | 132.20M | 171.00M | 63.70M |
Other items | - | - | - | - | - |
Income tax expense | 145.20M | 91.60M | 150.90M | 111.50M | 70.80M |
Total revenue | 5802.30M | 5045.20M | 4642.10M | 4609.80M | 4285.30M |
Total operating expenses | 1089.40M | 1018.80M | 1017.60M | 1091.00M | 1077.70M |
Cost of revenue | 3475.50M | 2873.50M | 2590.10M | 2526.20M | 2405.50M |
Total other income expense net | -75.50000M | -68.20000M | -120.70000M | -179.40000M | -60.60000M |
Discontinued operations | -97.20000M | -68.20000M | -28.30000M | -63.30000M | -143.40000M |
Net income from continuing ops | 838.70M | 802.20M | 578.90M | 543.50M | 654.90M |
Net income applicable to common shares | 736.50M | 736.50M | 551.50M | 477.40M | 502.10M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 11171.30M | 10581.30M | 10186.40M | 9872.70M | 9974.30M |
Intangible assets | 2508.10M | 2521.90M | 2625.20M | 2629.00M | 2767.50M |
Earning assets | - | - | - | - | - |
Other current assets | 343.60M | 41.60M | 32.20M | 53.00M | 59.30M |
Total liab | 7770.40M | 7529.40M | 7202.20M | 7311.30M | 6763.90M |
Total stockholder equity | 3400.90M | 3051.90M | 2984.20M | 2561.40M | 3121.10M |
Deferred long term liab | 321.50M | 342.40M | 350.00M | 333.20M | 330.80M |
Other current liab | 1326.10M | 1313.80M | 1196.90M | 1103.40M | 1016.70M |
Common stock | 18.60M | 18.60M | 18.60M | 18.60M | 18.60M |
Capital stock | 18.60M | 18.60M | 18.60M | 18.60M | 18.60M |
Retained earnings | 5555.90M | 4991.30M | 4506.40M | 4188.80M | 4334.30M |
Other liab | 1109.00M | 1277.40M | 1443.70M | 1393.10M | 1608.20M |
Good will | 1589.30M | 1463.30M | 1468.90M | 1467.50M | 1468.10M |
Other assets | 453.60M | 841.50M | 947.00M | 661.00M | 953.20M |
Cash | 572.00M | 516.80M | 568.90M | 339.10M | 161.70M |
Cash and equivalents | 572.00M | 516.80M | 568.90M | 339.10M | 134.40M |
Total current liabilities | 3799.60M | 3520.30M | 2829.00M | 2723.90M | 2993.40M |
Current deferred revenue | 680.50M | 630.70M | 347.10M | 492.70M | 561.50M |
Net debt | 2702.00M | 2655.70M | 2698.90M | 2919.70M | 2582.30M |
Short term debt | 540.80M | 440.80M | 338.30M | 227.70M | 547.70M |
Short long term debt | 540.80M | 440.80M | 338.30M | 227.70M | 547.70M |
Short long term debt total | 3274.00M | 3172.50M | 3267.80M | 3258.80M | 2744.00M |
Other stockholder equity | -1714.00000M | -1642.30000M | -1258.60000M | -1234.00000M | -922.90000M |
Property plant equipment | 849.60M | 817.00M | 771.70M | 758.00M | 1032.60M |
Total current assets | 5438.60M | 4937.60M | 4375.60M | 4074.80M | 4030.20M |
Long term investments | 14.50M | 9.20M | 3.10M | 0.70M | 0.70M |
Net tangible assets | 869.80M | -933.30000M | 336.60M | -1564.20000M | -1051.30000M |
Short term investments | - | - | 3.00M | - | 29.10M |
Net receivables | 2871.40M | 2583.70M | 2330.30M | 2231.20M | 2507.70M |
Long term debt | 2733.20M | 2731.70M | 2929.50M | 3031.10M | 2179.00M |
Inventory | 1651.60M | 1405.70M | 1095.60M | 1017.00M | 1097.30M |
Accounts payable | 1252.20M | 1135.00M | 946.70M | 900.10M | 867.50M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | 23.00M | 19.40M | 22.40M | 29.10M | 89.30M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -459.60000M | -315.70000M | -282.20000M | -412.00000M | -308.90000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 18.60M | 18.60M | 18.60M | 18.60M | 18.60M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 5555.90M | 4991.30M | 4506.40M | 4188.80M | 4334.30M |
Treasury stock | -2646.20000M | -2542.10000M | -2141.20000M | -2092.80000M | -1699.10000M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 560.50M | 613.80M | 712.30M | 685.30M | 356.80M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 5732.70M | 5643.70M | 5810.80M | 5797.90M | 5944.10M |
Capital lease obligations | 150.60M | 163.50M | 176.70M | 194.70M | 17.30M |
Long term debt total | 2733.20M | 2731.70M | 2929.50M | 3031.10M | 2179.00M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -266.40000M | -112.00000M | -169.30000M | -186.70000M | 88.00M |
Change to liabilities | 184.40M | 54.10M | 98.00M | 78.00M | 87.40M |
Total cashflows from investing activities | -266.40000M | -112.00000M | -200.40000M | -195.90000M | -115.90000M |
Net borrowings | 113.80M | -100.60000M | 20.60M | 488.80M | -441.60000M |
Total cash from financing activities | -237.40000M | -747.90000M | -250.30000M | -124.20000M | -363.30000M |
Change to operating activities | -35.50000M | -0.40000M | -36.30000M | -388.30000M | -40.90000M |
Net income | 838.70M | 802.20M | 578.90M | 543.50M | 654.90M |
Change in cash | 55.20M | -52.10000M | 229.80M | 177.40M | -121.30000M |
Begin period cash flow | 516.80M | 568.90M | 339.10M | 161.70M | 283.00M |
End period cash flow | 572.00M | 516.80M | 568.90M | 339.10M | 161.70M |
Total cash from operating activities | 582.40M | 820.10M | 647.80M | 488.50M | 368.40M |
Issuance of capital stock | 9.40M | 7.90M | 24.70M | 50.70M | 374.30M |
Depreciation | 169.40M | 170.90M | 162.70M | 150.10M | 168.20M |
Other cashflows from investing activities | -124.10000M | -112.00000M | -102.10000M | -92.80000M | -62.30000M |
Dividends paid | -267.50000M | -247.20000M | -228.50000M | -210.30000M | 89.20M |
Change to inventory | -182.30000M | -331.10000M | -59.70000M | 6.40M | -224.20000M |
Change to account receivables | -443.90000M | -241.10000M | -71.80000M | -123.50000M | -302.20000M |
Sale purchase of stock | -108.90000M | -408.00000M | -58.40000M | -416.20000M | -206.80000M |
Other cashflows from financing activities | 131.00M | 1102.50M | 111.90M | 1353.50M | 110.40M |
Change to netincome | -110.60000M | 820.10M | -41.10000M | -8.80000M | -139.60000M |
Capital expenditures | 142.30M | 100.10M | 67.20M | 93.90M | 156.60M |
Change receivables | -443.90000M | -241.10000M | -71.80000M | -123.50000M | -302.20000M |
Cash flows other operating | 965.40M | 1223.60M | 559.70M | -700.70000M | 778.80M |
Exchange rate changes | - | -12.30000M | 1.60M | -0.20000M | 4.50M |
Cash and cash equivalents changes | 156.20M | 6.70M | 287.70M | 272.50M | -121.30000M |
Change in working capital | -358.10000M | -121.80000M | -127.00000M | -265.90000M | -212.20000M |
Stock based compensation | 24.20M | 17.80M | 18.90M | 25.60M | 23.00M |
Other non cash items | -39.10000M | -58.70000M | -19.30000M | -10.90000M | -218.10000M |
Free cash flow | 440.10M | 720.00M | 580.60M | 394.60M | 211.80M |
Sector: Basic Materials Industry: Agricultural Inputs
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
FMC FMC Corporation |
1.43 2.56% | 57.03 | 12.97 | 13.39 | 1.53 | 2.23 | 2.24 | 10.15 |
CTVA Corteva Inc |
0.73 1.25% | 58.97 | 30.23 | 15.58 | 1.89 | 1.30 | 2.10 | 13.87 |
NTR Nutrien Ltd |
0.36 0.79% | 45.92 | 12.97 | 10.67 | 0.92 | 1.09 | 1.36 | 6.80 |
CF CF Industries Holdings Inc |
2.37 2.71% | 89.91 | 7.48 | 11.42 | 1.94 | 2.60 | 1.94 | 3.73 |
MOS The Mosaic Company |
0.05 0.20% | 25.44 | 9.17 | 11.07 | 0.78 | 0.98 | 1.00 | 5.38 |
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
2929 Walnut Street, Philadelphia, PA, United States, 19104
Name | Title | Year Born |
---|---|---|
Mr. Mark A. Douglas | Pres, CEO & Director | 1962 |
Mr. Andrew D. Sandifer | Exec. VP & CFO | 1970 |
Dr. Kathleen A. Shelton Ph.D. | Exec. VP & CTO | 1962 |
Mr. Michael Finian Reilly | Exec. VP, Gen. Counsel, Chief Compliance Officer & Sec. | 1964 |
Mr. Ronaldo Pereira | Exec. VP & Pres of Americas | 1973 |
Mr. Barry J. Crawford | VP of Operations | NA |
Mr. Nicholas L. Pfeiffer | VP, Corp. Controller & Chief Accounting Officer | NA |
Mr. David A. Kotch | VP & Chief Information Officer | NA |
Mr. Abizar Zaki | Investor Relations Director | NA |
Mr. Kenneth A. Gedaka | VP of Communications & Public Affairs | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.